Abstract
Background
We studied the characteristics of ST-elevation myocardial infarction (STEMI) patients from a local acute coronary syndrome (ACS) registry in order to find and build an appropriate acute myocardial infarction (AMI) system of care in Jakarta, Indonesia.
Methods
Data were collected from the Jakarta Acute Coronary Syndrome (JAC) registry 2008–2009, which contained 2103 ACS patients, including 654 acute STEMI patients admitted to the National Cardiovascular Center Harapan Kita, Jakarta, Indonesia.
Results
The proportion of patients who did not receive reperfusion therapy was 59% in all STEMI patients and the majority of them (52%) came from inter-hospital referral. The time from onset of infarction to hospital admission was more than 12 h in almost 80% cases and 60% had an anterior wall MI. In-hospital mortality was significantly higher in patients who did not receive reperfusion therapy compared with patients receiving acute reperfusion therapy, either with primary percutaneous coronary intervention (PPCI) or fibrinolytic therapy (13.3% vs 5.3% vs 6.2%, p < 0.001).
Conclusion
The Jakarta Cardiovascular Care Unit Network System was built to improve the care of AMI in Jakarta. This network will harmonise the activities of all hospitals in Jakarta and will provide the best cardiovascular services to the community by giving two reperfusion therapy options (PPCI or pharmaco-invasive strategy) depending on the time needed for the patient to reach the cath-lab.
Similar content being viewed by others
References
Dalby M, Bouzamondo A, Lechat P, et al. Transfer for primary angioplasty versus immediate thrombolysis in acute myocardial infarction: a meta-analysis. Circulation 2003;1809–14.
Keeley EC, Boura JA, Grines CL. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomized trials. Lancet. 2003;361:13–20.
Danchin N. System of care for ST-segment elevation myocardial infarction. Impact of different models on clinical outcomes. J Am Coll Cardiol Intv. 2009;2:901–8.
Kusmana D. Jakarta Cardiovascular Study: The city that promotes Indonesia Healthy Heart, Report I 2006.
National Health Survey 2006, Ministry of Health, Republic of Indonesia, 2006.
Kusmana D. The influence of smoking or stop smoking followed by regular exercise and/or effect of physical exertion on survival in Jakarta population: a 13 years cohort study. Dissertation of PhD thesis, Faculty of Medicine, University of Indonesia, 2002.
Jakarta Demographic Survey 2010, Government of Jakarta, Indonesia.
Galenta Y, Dharma S. ST-segment elevation myocardial infarction characteristic in National Cardiovascular Center Harapan Kita. Abstract session in the 19th Annual Scientific Meeting of Indonesian Heart Association, Jakarta, April 2010.
Kushner FG, Hand M, Smith SC, et al. 2009 Focused Updates: ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction (updating the 2004 guideline and 2007 focused update) and ACC/AHA/SCAI guidelines on percutaneous coronary intervention (updating the 2005 guideline and 2007 focused update): Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2009;120:2271–306.
Kalla K, Christ G, Karnik R, et al. Implementation of guidelines improves the standard of care: the Viennese registry on reperfusion strategies in ST-elevation myocardial infarction (Vienna STEMI registry). Circulation. 2006;113:2398–405.
Danchin N, Coste P, Ferrieres J, et al. Comparison of thrombolysis followed by broad use of percutaneous coronary intervention with primary percutaneous coronary intervention for ST-segment elevation acute myocardial infarction: data from the French registry on acute ST-elevation myocardial infarction (FAST-MI). Circulation. 2008;118:268–76.
Henry TD, Scott WS, Burke MN, et al. A regional system to provide timely access to percutaneous coronary intervention for ST-elevation myocardial infarction. Circulation. 2007;116:721–8.
Ting HH, Rihal CS, Gersh BJ, et al. Regional system of care to optimize timeliness of reperfusion therapy for ST-elevation myocardial infarction: the MAYO Clinic STEMI protocol. Circulation. 2007;116:729–36.
Andersen HR, Nielsen TT, Rasmussen K, et al. A comparison of coronary angioplasty with fibrinolytic therapy in acute myocardial infarction. N Engl J Med. 2003;349:733–42.
Boersma E, Maas AC, Deckers JW, et al. Early thrombolytic treatment in acute myocardial infarction: reappraisal of the golden hour. Lancet. 1996;348:771–5.
Juliard JM, Feldman LJ, Golmard JL, et al. Relation of mortality of primary angioplasty during acute myocardial infarction to door-to-Thrombolysis in Myocardial Infarction (TIMI) time. Am J Cardiol. 2003;91:1401–5.
Cannon CP, Gibson M, Lambrew CT, et al. Relationship of symptom-onset-to-balloon time and door-to-balloon time with mortality in patients undergoing angioplasty for acute myocardial infarction. JAMA. 2000;283:2941–7.
De Luca G, Suryapranata H, Ottervanger JP, et al. Time delay to treatment and mortality in primary angioplasty for acute myocardial infarction. Circulation. 2004;109:1223–5.
Nallamothu BK, Bates ER. Percutaneous coronary intervention versus fibrinolytic therapy in acute myocardial infarction: is timing (almost) everything? Am J Cardiol. 2003;92:824–6.
Pinto DS, Kirtane AJ, Nallamothu BK, et al. Hospital delays in reperfusion for ST-elevation myocardial infarction: Implications when selecting a reperfusion strategy. Circulation. 2006;114:2019–25.
Betriu A, Masotti M. Comparison of mortality rates in acute myocardial infarction treated by percutaneous coronary intervention versus fibrinolysis. Am J Cardiol. 2005;95:100–1.
Rathore SS, Curtis JP, Chen J, et al. Association of door-to-balloon time and mortality in patients admitted to hospital with ST elevation myocardial infarction: national cohort study. BMJ. 2009;338:1807–13.
Nallamothu BK, Bates ER, Herrin J, et al. NRMI Investigators. Times to treatment in transfer patients undergoing primary percutaneous coronary intervention in the United States: National Registry of Myocardial Infarction (NRMI)- 3/4 analysis. Circulation. 2005;111:761–7.
Eagle KA, Nallamothu BK, Mehta RH, et al. for the Global Registry of Acute Coronary Events (GRACE) Investigators. Trends in acute reperfusion therapy for ST-segment elevation myocardial infarction from 1999 to 2006: we are getting better but we have got a long way to go. Eur Heart J. 2008;29:609–17.
Widimsky P, Wijns W, Fajadet J, et al. Reperfusion therapy for ST elevation acute myocardial infarction in Europe: description of the current situation in 30 countries. Eur Heart J. 2010;31:943–57.
Gibson CM, Karha J, Murphy SA, et al. Early and long-term clinical outcomes associated with reinfarction following fibrinolytic administration in the thrombolysis in myocardial infarction trials. J Am Coll Cardiol. 2003;42:7–16.
Gershlick AH, Stephens-Lloyd A, Hughes S, et al. for the REACT Trial Investigators. Rescue angioplasty after failed thrombolytic therapy for acute myocardial infarction. N Engl J Med. 2005;353:2758–68.
Verheugt FWA. Routine angioplasty after fibrinolysis—How early should “early” be? N Engl J Med. 2009;360:2779–81.
Van de Werf F. Pharmaco-invasive vs. Facilitated percutaneous coronary intervention strategies for ST-segment elevation acute myocardial infarction patients in the new ESC Guidelines. Eur Heart J. 2009;30:2817.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Dharma, S., Juzar, D.A., Firdaus, I. et al. Acute myocardial infarction system of care in the third world. Neth Heart J 20, 254–259 (2012). https://doi.org/10.1007/s12471-012-0259-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12471-012-0259-9